These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 18182984

  • 1. Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial.
    Nehls O, Oettle H, Hartmann JT, Hofheinz RD, Hass HG, Horger MS, Koppenhöfer U, Hochhaus A, Stieler J, Trojan J, Gregor M, Klump B.
    Br J Cancer; 2008 Jan 29; 98(2):309-15. PubMed ID: 18182984
    [Abstract] [Full Text] [Related]

  • 2. Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study.
    Gunnlaugsson A, Anderson H, Lind P, Glimelius B, Johnsson A.
    Radiother Oncol; 2010 Jun 29; 95(3):292-7. PubMed ID: 20451275
    [Abstract] [Full Text] [Related]

  • 3. A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer.
    Kim GM, Jeung HC, Rha SY, Kim HS, Jung I, Nam BH, Lee KH, Chung HC.
    Eur J Cancer; 2012 Mar 29; 48(4):518-26. PubMed ID: 22243774
    [Abstract] [Full Text] [Related]

  • 4. A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract.
    Graham JS, Boyd K, Coxon FY, Wall LR, Eatock MM, Maughan TS, Highley M, Soulis E, Harden S, Bützberger-Zimmerli P, Evans TR.
    BMC Res Notes; 2016 Mar 12; 9():161. PubMed ID: 26969121
    [Abstract] [Full Text] [Related]

  • 5. Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomized phase II study.
    Rosati G, Cordio S, Bordonaro R, Caputo G, Novello G, Reggiardo G, Manzione L.
    Ann Oncol; 2010 Apr 12; 21(4):781-786. PubMed ID: 19713248
    [Abstract] [Full Text] [Related]

  • 6. Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study.
    Lee J, Park SH, Chang HM, Kim JS, Choi HJ, Lee MA, Jang JS, Jeung HC, Kang JH, Lee HW, Shin DB, Kang HJ, Sun JM, Park JO, Park YS, Kang WK, Lim HY.
    Lancet Oncol; 2012 Feb 12; 13(2):181-8. PubMed ID: 22192731
    [Abstract] [Full Text] [Related]

  • 7. Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial.
    Hess V, Pratsch S, Potthast S, Lee L, Winterhalder R, Widmer L, Cescato C, Lohri A, Jost L, Stillhart P, Pestalozzi B, Herrmann R.
    Ann Oncol; 2010 Dec 12; 21(12):2390-2395. PubMed ID: 20444846
    [Abstract] [Full Text] [Related]

  • 8. Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer.
    Boeck S, Hoehler T, Seipelt G, Mahlberg R, Wein A, Hochhaus A, Boeck HP, Schmid B, Kettner E, Stauch M, Lordick F, Ko Y, Geissler M, Schoppmeyer K, Kojouharoff G, Golf A, Neugebauer S, Heinemann V.
    Ann Oncol; 2008 Feb 12; 19(2):340-7. PubMed ID: 17962204
    [Abstract] [Full Text] [Related]

  • 9. Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer.
    Koeberle D, Burkhard R, von Moos R, Winterhalder R, Hess V, Heitzmann F, Ruhstaller T, Terraciano L, Neuweiler J, Bieri G, Rust C, Toepfer M.
    Br J Cancer; 2008 Apr 08; 98(7):1204-9. PubMed ID: 18349837
    [Abstract] [Full Text] [Related]

  • 10. [Comparison between the effects of irinotecan or oxaliplatin combined with capecitabine in the treatment of advanced gastric cancer].
    Zhao WY, Chen DY, Qi Q.
    Zhonghua Zhong Liu Za Zhi; 2011 Apr 08; 33(4):295-8. PubMed ID: 21575503
    [Abstract] [Full Text] [Related]

  • 11. Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study.
    André T, Tournigand C, Rosmorduc O, Provent S, Maindrault-Goebel F, Avenin D, Selle F, Paye F, Hannoun L, Houry S, Gayet B, Lotz JP, de Gramont A, Louvet C, GERCOR Group.
    Ann Oncol; 2004 Sep 08; 15(9):1339-43. PubMed ID: 15319238
    [Abstract] [Full Text] [Related]

  • 12. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.
    Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, Lee KW, Kim YH, Noh SI, Cho JY, Mok YJ, Kim YH, Ji J, Yeh TS, Button P, Sirzén F, Noh SH, CLASSIC trial investigators.
    Lancet; 2012 Jan 28; 379(9813):315-21. PubMed ID: 22226517
    [Abstract] [Full Text] [Related]

  • 13. A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma.
    Brell JM, Krishnamurthi SS, Javle M, Saltzman J, Wollner I, Pelley R, Dowlati A, Kantharaj BN, Schluchter MD, Rath L, Ivy SP, Remick SC.
    Cancer Chemother Pharmacol; 2009 Apr 28; 63(5):851-7. PubMed ID: 18670776
    [Abstract] [Full Text] [Related]

  • 14. A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study.
    LoConte NK, Holen KD, Schelman WR, Mulkerin DL, Deming DA, Hernan HR, Traynor AM, Goggins T, Groteluschen D, Oettel K, Robinson E, Lubner SJ.
    Invest New Drugs; 2013 Aug 28; 31(4):943-8. PubMed ID: 23263993
    [Abstract] [Full Text] [Related]

  • 15. Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial.
    Seymour MT, Thompson LC, Wasan HS, Middleton G, Brewster AE, Shepherd SF, O'Mahony MS, Maughan TS, Parmar M, Langley RE, FOCUS2 Investigators, National Cancer Research Institute Colorectal Cancer Clinical Studies Group.
    Lancet; 2011 May 21; 377(9779):1749-59. PubMed ID: 21570111
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prospective phase I study of capecitabine and oxaliplatin concurrent with radiation therapy for the treatment of locally advanced pancreatic adenocarcinoma, and retrospective comparison to concurrent 5-fluorouracil/radiation and gemcitabine/radiation.
    Hazard L, Jones K, Shaban A, Anker C, Scaife C, Weis J, Mulvihill S.
    J Gastrointest Cancer; 2012 Jun 21; 43(2):258-66. PubMed ID: 21243531
    [Abstract] [Full Text] [Related]

  • 19. A phase II study of bevacizumab, oxaliplatin, and capecitabine in patients with previously untreated metastatic colorectal cancer: a prospective, multicenter trial of the Korean Cancer Study Group.
    Hong YS, Lee SS, Kim KP, Lee JL, Kang YK, Shin SJ, Ahn JB, Jung KH, Im SA, Kim TY, Kim JH, Park YS, Kim TW.
    Am J Clin Oncol; 2014 Feb 21; 37(1):19-23. PubMed ID: 23111359
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.